Literature DB >> 32358845

Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services.

Luiz Henrique Arroyo1, Mellina Yamamura2, Antônio Carlos Vieira Ramos1, Laura Terenciani Campoy1, Juliane de Almeida Crispim1, Thais Zamboni Berra1, Luana Seles Alves1, Yan Mathias Alves1, Felipe Lima Dos Santos1, Ludmilla Leidianne Limirio Souza1, Alexandre Tadashi Inomata Bruce1, Hamilton Leandro Pinto de Andrade1, Valdes Roberto Bollela3, Elias Teixeira Krainski4, Carla Nunes5, Ricardo Alexandre Arcêncio1.   

Abstract

OBJECTIVE: Multidrug-resistant tuberculosis (MDR-TB) remains a serious public health problem worldwide. Accordingly, this study sought to identify individual, community and access to health services risk factors for MDR-TB.
METHODS: Retrospective cohort of all TB cases diagnosed between 2006 and 2016 in the state of São Paulo. A Bayesian spatial hierarchical analysis with a multilevel design was carried out.
RESULTS: It was identified that the history of previous TB treatment (Odds Ratios [OR]:13.86, 95% credibility interval [95% CI]:12.06-15.93), positive sputum culture test (OR: 5.26, 95% CI: 4.44-6.23), diabetes mellitus (OR: 2.34, 95% CI: 1.87-2.91), residing at a standard address (OR: 2.62, 95% CI: 1.91-3.60), positive sputum smear microscopy (OR: 1.74, 95% CI: 1.44-2.12), cavitary pulmonary TB (OR: 1.35, 95% CI: 1.14-1.60) and diagnosis performed due to spontaneous request (OR: 1.26; 95% CI: 1.10-1.46) were associated with MDR-TB. Furthermore, municipalities that performed HIV tests in less than 42.65% of patients with TB (OR: 1.50, 95% CI: 1.25-1.79), that diagnosed TB cases only after death (OR: 1.50, 95% CI: 1.17-1.93) and that had more than 20.16% of their population with income between ¼ and ½ of one minimum wage (OR: 1.56, 95% CI: 1.30-1.87) were also related to the MDR-TB.
CONCLUSIONS: Knowledge of these predictive factors may help to develop more comprehensive disease prevention strategies for MDR-TB, avoiding the risks expressed regarding drug resistance expansion.
© 2020 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  access; accès et évaluation des soins de santé; and evaluation; communicable disease control; facteurs de risque; facteurs socioéconomiques; health care quality; lutte contre les maladies transmissibles; multidrug-resistant tuberculosis; qualité; risk factors; socioeconomic factors; tuberculose multirésistante

Year:  2020        PMID: 32358845     DOI: 10.1111/tmi.13409

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  3 in total

1.  Identifying Hotspots of People Diagnosed of Tuberculosis with Addiction to Alcohol, Tobacco, and Other Drugs through a Geospatial Intelligence Application in Communities from Southern Brazil.

Authors:  Alessandro Rolim Scholze; Felipe Mendes Delpino; Luana Seles Alves; Josilene Dália Alves; Thaís Zamboni Berra; Antônio Carlos Vieira Ramos; Miguel Fuentealba-Torres; Inês Fronteira; Ricardo Alexandre Arcêncio
Journal:  Trop Med Infect Dis       Date:  2022-05-24

2.  Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.

Authors:  Felipe Lima Dos Santos; Ludmilla Leidianne Limirio Souza; Alexandre Tadashi Inomata Bruce; Juliane de Almeida Crispim; Luiz Henrique Arroyo; Antônio Carlos Vieira Ramos; Thaís Zamboni Berra; Yan Mathias Alves; Alessandro Rolim Scholze; Fernanda Bruzadelli Paulino da Costa; José Francisco Martoreli Júnior; Ana Carolina Scarpel Moncaio; Ione Carvalho Pinto; Ricardo Alexandre Arcêncio
Journal:  PLoS One       Date:  2021-04-09       Impact factor: 3.240

3.  Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study.

Authors:  Arnaud Iradukunda; Gabin-Pacifique Ndayishimiye; Darlene Sinarinzi; Emmanuel Nene Odjidja; Nestor Ntakaburimvo; Innocent Nshimirimana; Cheilla Izere
Journal:  BMC Public Health       Date:  2021-11-23       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.